Study Comparing 4 Cycles With 6 Cycles of TC Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer
Condition: Breast Cancer Interventions: Drug: Docetaxel; Drug: Cyclophosphamide Sponsor: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | HER2 | Research | Study | Taxotere